Cargando…

The inositols and polycystic ovary syndrome

This review describes the rationale, biochemical, and clinical data related to the use of inositols in polycystic ovary syndrome (PCOS). It covers studies related to the mechanism of action of myo-inositol and D-chiro-inositol (MDI), with randomized controlled trials conducted in women with PCOS, an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kalra, Bharti, Kalra, Sanjay, Sharma, J. B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040057/ https://www.ncbi.nlm.nih.gov/pubmed/27730087 http://dx.doi.org/10.4103/2230-8210.189231

Ejemplares similares

Inositols in Midlife
por: Kalra, Sanjay, et al.
Publicado: (2018)

Primary Care Screening Tool for Polycystic Ovary Syndrome: Step One in the Battle Against Non-Communicable Disease
por: Kalra, Sanjay, et al.
Publicado: (2023)

A Practitioner’s Toolkit for Polycystic Ovary Syndrome Counselling
por: Lathia, Tejal, et al.
Publicado: (2022)

Bone morphogenetic proteins and the polycystic ovary syndrome
por: van Houten, E Leonie AF, et al.
Publicado: (2013)

Hypoglycemia perception: Cross-cultural differences in Punjabi and Hindi speaking postmenopausal women
por: Bhutani, Jaikrit, et al.
Publicado: (2013)

Prevalence of Pharamcologically-treated Diabetes in Term Pregnancies in Haryana, India
por: Kalra, Bharti, et al.
Publicado: (2017)

Polycystic Ovary Syndrome: Insights into the Therapeutic Approach with Inositols
por: Sortino, Maria A., et al.
Publicado: (2017)

Polycystic Ovary Syndrome and COVID-19: An Emerging Risk Factor
por: Joshi, Shashank R.
Publicado: (2021)

Polycystic ovarian morphology in Thai women of reproductive age with polycystic ovary syndrome
por: Wongwananuruk, Thanyarat, et al.
Publicado: (2020)

The “Asthma-Polycystic Ovary Overlap Syndrome” and the Therapeutic Role of Myo-Inositol
por: Guarnieri, Gabriella, et al.
Publicado: (2023)

Management of polycystic ovary syndrome among Indian women using myo‐inositol and D-chiro-inositol
por: Vyas, Lila, et al.
Publicado: (2022)

Myo-inositol for insulin resistance, metabolic syndrome, polycystic ovary syndrome and gestational diabetes
por: DiNicolantonio, James J, et al.
Publicado: (2022)

Polycystic ovary syndrome – A metabolic malady, the mother of all lifestyle disorders in women – Can Indian health budget tackle it in future?
por: Ganie, M. Ashraf, et al.
Publicado: (2011)

The significance of anthropometric and endocrine parameters in ovulation induction with clomiphene citrate in women with polycystic ovary syndrome
por: Akpinar, Funda, et al.
Publicado: (2016)

The effects of a low-carbohydrate, ketogenic diet on the polycystic ovary syndrome: A pilot study
por: Mavropoulos, John C, et al.
Publicado: (2005)

Insulin degludec and insulin degludec/insulin aspart in Ramadan: A single center experience
por: Kalra, Sanjay
Publicado: (2016)

Basal insulin analogues in the treatment of diabetes mellitus: What progress have we made?
por: Kalra, Sanjay
Publicado: (2015)

High Concentration Insulin
por: Kalra, Sanjay
Publicado: (2018)

Prevalence of polycystic ovary syndrome in young women from North India: A Community-based study
por: Gill, Harmandeep, et al.
Publicado: (2012)

Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies
por: Merviel, Philippe, et al.
Publicado: (2021)

Vascular legacy: HOPE ADVANCEs to EMPA-REG and LEADER: A Surprising similarity
por: Kalra, Sanjay, et al.
Publicado: (2017)

Evidence-Based and Patient-Oriented Inositol Treatment in Polycystic Ovary Syndrome: Changing the Perspective of the Disease
por: Laganà, Antonio Simone, et al.
Publicado: (2017)

Comparing the Efficacy of Myo-Inositol Plus α-Lactalbumin vs. Myo-Inositol Alone on Reproductive and Metabolic Disturbances of Polycystic Ovary Syndrome
por: Kamenov, Zdravko, et al.
Publicado: (2023)

Short-term outcomes of type 2 diabetes mellitus patients treated with canagliflozin in real-world setting
por: Baruah, Manash P., et al.
Publicado: (2016)

Pharmacological Management of Obesity in Patients with Polycystic Ovary Syndrome
por: Kourtidou, Christodoula, et al.
Publicado: (2023)

Endocrine hygiene
por: Kalra, Sanjay, et al.
Publicado: (2016)

Sodium-glucose cotransporter-2 inhibition and the insulin: Glucagon ratio: Unexplored dimensions
por: Kalra, Sanjay, et al.
Publicado: (2015)

Sodium glucose transporter 2 (SGLT2) inhibition and ketogenesis
por: Kalra, Sanjay, et al.
Publicado: (2015)

Newer antidiabetic drugs and calorie restriction mimicry
por: Kalra, Sanjay, et al.
Publicado: (2016)

Flexibility in insulin prescription
por: Kalra, Sanjay, et al.
Publicado: (2016)

Effective management of type 2 DM in India: Looking at low-cost adjunctive therapy
por: Aswathy, Sreedevi, et al.
Publicado: (2013)

Metformin: Midlife maturity, maiden charm
por: Kalra, Sanjay, et al.
Publicado: (2012)

Metformin + Sodium-glucose Co-transporter-2 Inhibitor: Salutogenic Lifestyle Mimetics in a Tablet?
por: Kalra, Sanjay, et al.
Publicado: (2018)

Salutogenesis in Type 2 Diabetes Care: A Biopsychosocial Perspective
por: Kalra, Sanjay, et al.
Publicado: (2018)

Diabetes Destiny in our Hands: Achieving Metabolic Karma
por: Kalra, Sanjay, et al.
Publicado: (2017)

Trends in endocrine onomastics: The case of polycystic ovarian syndrome
por: Kalra, Sanjay, et al.
Publicado: (2013)

Vulvodynia: An unrecognized diabetic neuropathic syndrome
por: Kalra, Bharti, et al.
Publicado: (2013)

The Renal Pentad
por: Kalra, Sanjay, et al.
Publicado: (2018)

Thyro-stress
por: Kalra, Sanjay, et al.
Publicado: (2017)

Artificial Intelligence/Machine Learning in Diabetes Care
por: Singla, Rajiv, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_062vogbu3mnmnthlfhj2n37tjf